Loading company…
TYRX develops implantable medical devices that deliver therapeutic agents to help prevent infections linked to surgical implants.
TYRX develops implantable devices that deliver therapeutic agents to address infections associated with surgical implants. Founded in 1998 in the US, it was acquired by Medtronic, Inc. in January 2014. Its listed valuation was USD 51.51 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in